Neoadjuvant chemotherapy with Vinorelbine and Epirubicin in locally advanced breast cancer (LABC).

被引：0
|
作者：
Puerto, VL
Cardenas, J
Lara, F
Goana, R
Silva, A
Barroso, N
机构：
[1] IMSS CMN Siglo XXI, Mexico City, DF, Mexico
[2] Ctr Estatal Cancerol, Colima, Mexico
[3] INCAN, Tlalpan, Mexico
[4] Hosp Gen Dr M Silva, Morelia, Michoacan, Mexico
[5] Hosp Dr A Leano, Zapopan, Mexico
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
512
引用
收藏
页码：299 / 299
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Iqbal, Javeria
    Shafi, Alam Ara
    Alharthi, Bandar N.
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2014, 24 (11): : 845 - 848
  • [22] Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
    Specht, Jennifer
    Gralow, Julie R.
    SEMINARS IN RADIATION ONCOLOGY, 2009, 19 (04) : 222 - 228
  • [23] Neoadjuvant chemotherapy for locally advanced breast cancer
    Fomenko, Y.
    Sirota, V.
    Bitz, U.
    Zhumakaeva, S.
    Omarova, I.
    Kabildina, N.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] Neoadjuvant Chemotherapy with Vinorelbine-containing Regimens in Elderly Patients with Locally Advanced Breast Cancer
    Ma, Chuan-Dong
    Chen, Can-Ming
    Chen, Xiao-Song
    Liu, Guang-Yu
    Di, Gen-Hong
    Wu, Jiong
    Lu, Jin-Song
    Yang, Wen-Tao
    Chen, Jia-Yi
    Shao, Zhi-Min
    Shen, Zhen-Zhou
    Shen, Kun-Wei
    ANTICANCER RESEARCH, 2008, 28 (5B) : 3093 - 3097
  • [25] A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer
    Lee, Jinsun
    Kim, Jeryong
    Chang, Eilsung
    Choi, Woonjung
    Lee, Kwangman
    Yoon, Hyunjo
    Jung, Sunghoo
    Park, Minho
    Yoon, Junghan
    Kim, Sungyong
    JOURNAL OF BREAST CANCER, 2014, 17 (04) : 344 - 349
  • [26] Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer
    Won, Hye Sung
    Kim, Yong Seok
    Kim, Jeong Soo
    Chang, Eun Deok
    Na, Sae Jung
    Whang, In Yong
    Lee, Dong Soo
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (06): : 1489 - 1496
  • [27] Perioperative chemotherapy (CT) with induction sequential epirubicin (EPI) and docetaxel (DOC) followed by surgery and DOC or gemcitabine/vinorelbine (GEN) with radiotherapy for locally advanced breast cancer (LABC)
    Ardavanis, A.
    Kountourakis, P.
    Missitzis, I.
    Doufexis, D.
    Malliou, S.
    Zobolas, V.
    Pissakas, G.
    Sotiropoulou, A.
    Rigatos, G.
    EJC SUPPLEMENTS, 2008, 6 (07): : 136 - 136
  • [28] Neoadjuvant chemotherapy with epirubicin-vinorelbine and G-CSF in locoregionally advanced breast cancer: Our experience
    Savarino, A.
    Fabiano, E.
    Maniaci, V
    Puliafito, I
    Sauta, M. G.
    Bene, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 43 - 43
  • [29] Vinorelbine, epirubicin, and methotrexate (VEM) as primary treatment in locally advanced breast cancer
    Abrahamova, J
    Wagnerova, M
    Kubala, E
    Malec, V
    Simova, E
    Sirakova, I
    Pavlikova, E
    Machova, D
    Kocak, I
    Pavlikova, I
    Tuma, P
    Prausova, J
    Kroslakova, D
    Van Praagh, I
    ONCOLOGIST, 2001, 6 (04): : 347 - 352
  • [30] Sequential doxorubicine (DOX) and docetaxel (DOC) as neoadjuvant chemotherapy in locally advanced breast cancer (LABC): A pilot study
    Wynendaele, W
    Paridaens, R
    Christiaens, MR
    Van den Bogaert, W
    van Oosterom, AT
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S15 - S15
12345